Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Luca Burchini"'
Autor:
Beatrice Detti, Maria Grazia Carnevale, Sara Lucidi, Luca Burchini, Saverio Caini, Carolina Orsatti, Niccolò Bertini, Manuele Roghi, Vanessa di Cataldo, Simona Fondelli, Gianluca Ingrosso, Giulio Francolini, Daniele Scartoni, Angela Sardaro, Antonio Pisani, Silvia Scoccianti, Cynthia Aristei, Lorenzo Livi
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
PurposeBiochemical recurrence (BR) occurs in up to 40% of patients with prostate cancer (PCa) treated with primary radical prostatectomy (RP). Choline PET/CT may show, in a single-step examination, the site of tumor recurrence earlier than traditiona
Externí odkaz:
https://doaj.org/article/d9d3161bbc5542e5ba254323358a7748
Autor:
Giulio Francolini, Pietro Garlatti, Vanessa Di Cataldo, Beatrice Detti, Mauro Loi, Daniela Greto, Gabriele Simontacchi, Ilaria Morelli, Luca Burchini, Andrea Gaetano Allegra, Giulio Frosini, Michele Ganovelli, Viola Salvestrini, Emanuela Olmetto, Luca Visani, Carlotta Becherini, Marianna Valzano, Maria Grazia Carnevale, Manuele Roghi, Sergio Serni, Chiara Mattioli, Isacco Desideri, Lorenzo Livi
Publikováno v:
Cancers; Volume 15; Issue 3; Pages: 992
Biochemical recurrences after radical prostatectomy (RP) can be managed with curative purpose through salvage radiation therapy (SRT). RT dose escalation, such as stereotactic RT (SSRT), may improve relapse-free survival in this setting. STARR trial
Autor:
Giulio Francolini, Giulio Frosini, Vanessa Di Cataldo, Beatrice Detti, Maria Grazia Carnevale, Marco Banini, Anna Peruzzi, Viola Salvestrini, Luca Visani, Emanuela Olmetto, Carlotta Becherini, Andrea Allegra, Luca Burchini, Vieri Scotti, Monica Mangoni, Icro Meattini, Isacco Desideri, Lorenzo Livi
Publikováno v:
Journal of geriatric oncology.
Taxane-based chemotherapy is one of the main cornerstones for treatment of metastatic prostate cancer (mPCa). In aged and well-fit patients, an indication for taxane chemotherapy should remain similar to the general population. Aiming to explore pred
Autor:
Giulio Francolini, Mauro Loi, Lucia Pia Ciccone, Beatrice Detti, Vanessa Di Cataldo, Pamela Pinzani, Francesca Salvianti, Giulia Salvatore, Mariangela Sottili, Costanza Santini, Giulio Frosini, Luca Visani, Luca Burchini, Chiara Mattioli, Andrea Gaetano Allegra, Marianna Valzano, Cecilia Cerbai, Michele Aquilano, Viola Salvestrini, Isacco Desideri, Monica Mangoni, Icro Meattini, Lorenzo Livi
Publikováno v:
Medical Oncology. 39
Circulating tumor cells detection and ARV7 expression are associated with worse clinical outcomes in metastatic Castration-Resistant Prostate Cancer (mCRPC) undergoing Androgen Receptor Targeted Agents. ARFL, PSMA and PSA may help to refine prognosti
Autor:
Giulio Francolini, Arun Ghoshal, Saverio Caini, Tessa Piazzini, Carlotta Becherini, Beatrice Detti, Vanessa Di Cataldo, Marianna Valzano, Michele Ganovelli, Andrea Gaetano Allegra, Giulio Frosini, Luca Burchini, Luca Visani, Viola Salvestrini, Emanuela Olmetto, Mauro Loi, Gabriele Simontacchi, Isacco Desideri, Icro Meattini, Lorenzo Livi
Publikováno v:
Journal of Clinical Oncology. 41:489-489
489 Background: Radical cystectomy (RC) with or without perioperative chemotherapy is considered the standard treatment option for Muscle invasive bladder cancer (MIBC), despite poor oncological outcomes. However, RC is often burdened by significant
Autor:
Giulio Francolini, Michele Ganovelli, Vanessa Di Cataldo, Beatrice Detti, Andrea Gaetano Allegra, Luca Burchini, Carlotta Becherini, Giulio Frosini, Manuele Roghi, Viola Salvestrini, Ciro Franzese, Marta Scorsetti, Arturo Chiti, Martina Sollini, Isacco Desideri, Luca Vaggelli, Luca Visani, Emanuela Olmetto, Icro Meattini, Lorenzo Livi
Publikováno v:
Journal of Clinical Oncology. 41:137-137
137 Background: Main approach for early biochemical relapse (BR) after radical prostatectomy (RP) is prostate bed salvage radiotherapy (SRT). PSICHE is a prospective trial aimed to explore oncological results of a 68Ga-PSMA-11 PET/CT tailored strateg
Autor:
Giulio Francolini, Mauro Loi, Lucia Pia Ciccone, Monica Mangoni, Beatrice Detti, Vanessa Di Cataldo, Michele Aquilano, Andrea Allegra, Pamela Pinzani, Francesca Salvianti, Cecilia Cerbai, Luca Burchini, Giulio Frosini, Chiara Mattioli, Viola Salvestrini, Barbara Guerrieri, Giulia Salvatore, Mariangela Sottili, Isacco Desideri, Lorenzo Livi
Publikováno v:
Journal of Clinical Oncology. 40:137-137
137 Background: Circulating tumor cells (CTC) detection and androgen receptor splice variant 7 (ARV7) expression have been shown to be associated with worse clinical outcomes in metastatic castration resistant prostate cancer (mCRPC) patients undergo